141 related articles for article (PubMed ID: 9593142)
1. Disposition of the acyclic nucleoside phosphonate (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine.
Bijsterbosch MK; Smeijsters LJ; van Berkel TJ
Antimicrob Agents Chemother; 1998 May; 42(5):1146-50. PubMed ID: 9593142
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial and toxic effects of the acyclic nucleoside phosphonate (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine in Plasmodium berghei-infected mice.
Smeijsters LJ; Nieuwenhuijs H; Hermsen RC; Dorrestein GM; Franssen FF; Overdulve JP
Antimicrob Agents Chemother; 1996 Jul; 40(7):1584-8. PubMed ID: 8807044
[TBL] [Abstract][Full Text] [Related]
3. Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detection.
Naesens L; Balzarini J; De Clercq E
Clin Chem; 1992 Apr; 38(4):480-5. PubMed ID: 1568310
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
Quenelle DC; Collins DJ; Herrod BP; Keith KA; Trahan J; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2007 Nov; 51(11):3940-7. PubMed ID: 17846137
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
6. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
Aduma P; Connelly MC; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
[TBL] [Abstract][Full Text] [Related]
7. 5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives.
Balzarini J; De Clercq E
J Biol Chem; 1991 May; 266(14):8686-9. PubMed ID: 1851154
[TBL] [Abstract][Full Text] [Related]
8. Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.
de Vrueh RL; Rump ET; van De Bilt E; van Veghel R; Balzarini J; Biessen EA; van Berkel TJ; Bijsterbosch MK
Antimicrob Agents Chemother; 2000 Mar; 44(3):477-83. PubMed ID: 10681306
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.
Lin JC; De Clercq E; Pagano JS
Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake of phosphonylmethoxyalkylpurine derivatives.
Palú G; Stefanelli S; Rassu M; Parolin C; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):115-9. PubMed ID: 1776875
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the growth of Plasmodium falciparum and Plasmodium berghei by the DNA polymerase inhibitor HPMPA.
de Vries E; Stam JG; Franssen FF; Nieuwenhuijs H; Chavalitshewinkoon P; de Clercq E; Overdulve JP; van der Vliet PC
Mol Biochem Parasitol; 1991 Jul; 47(1):43-50. PubMed ID: 1857384
[TBL] [Abstract][Full Text] [Related]
13. Arrest of Trypanosoma brucei rhodesiense and T. brucei brucei in the S-phase of the cell cycle by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine ((S)-HPMPA).
Kaminsky R; Nickel B; Holý A
Mol Biochem Parasitol; 1998 May; 93(1):91-100. PubMed ID: 9662031
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
Balzarini J; Hatse S; Naesens L; De Clercq E
Biochim Biophys Acta; 1998 Mar; 1402(1):29-38. PubMed ID: 9551083
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of African swine fever virus DNA synthesis by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine.
Arzuza O; García-Villalón D; Tabarés E; Gil-Fernández C; De Clercq E
Biochem Biophys Res Commun; 1988 Jul; 154(1):27-32. PubMed ID: 3395330
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts.
Merta A; Veselý J; Votruba I; Rosenberg I; Holý A
Neoplasma; 1990; 37(2):111-20. PubMed ID: 2160620
[TBL] [Abstract][Full Text] [Related]
17. Novel hepatotrophic prodrugs of the antiviral nucleoside 9-(2-phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity.
Biessen EA; Valentijn AR; De Vrueh RL; Van De Bilt E; Sliedregt LA; Prince P; Bijsterbosch MK; Van Boom JH; Van Der Marel GA; Abrahams PJ; Van Berkel TJ
FASEB J; 2000 Sep; 14(12):1784-92. PubMed ID: 10973928
[TBL] [Abstract][Full Text] [Related]
18. The effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl) adenine on nuclear and organellar DNA synthesis in erythrocytic schizogony in malaria.
Smeijsters LJ; Zijlstra NM; de Vries E; Franssen FF; Janse CJ; Overdulve JP
Mol Biochem Parasitol; 1994 Sep; 67(1):115-24. PubMed ID: 7838172
[TBL] [Abstract][Full Text] [Related]
19. (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA]: a purine analogue with trypanocidal activity in vitro and in vivo.
Kaminsky R; Schmid C; Grether Y; Holý A; DeClercq E; Naesens L; Brun R
Trop Med Int Health; 1996 Apr; 1(2):255-63. PubMed ID: 8665394
[TBL] [Abstract][Full Text] [Related]
20. Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication.
Lin JC; DeClercq E; Pagano JS
Antimicrob Agents Chemother; 1987 Sep; 31(9):1431-3. PubMed ID: 2823699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
